# McCormick & Co Inc: overview

MKC · NYSE · CIK 63754 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/mkc.md) · [Financials](/companies/mkc/financials.md) · [Filings](/companies/mkc/filings.md) · [Insiders](/companies/mkc/insiders.md)

Latest reported revenue: [$2.02bn](/filings/0000063754-26-000329.md) for Q3 FY2026, three months to 2026-08-31, from the 10-Q filed Oct 1, 2026 (XBRL us-gaap:Revenues, accession 0000063754-26-000329).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,798 d](/filings/0000063754-26-000037.md) | [1,606](/filings/0000063754-26-000192.md) | [1,660](/filings/0000063754-26-000274.md) | [1,725](/filings/0000063754-26-000329.md) | [1,850 d](/filings/0000063754-26-000037.md) | [1,874](/filings/0000063754-26-000192.md) | [1,937](/filings/0000063754-26-000274.md) | [2,025](/filings/0000063754-26-000329.md) |
| Gross margin | % | [40.2% d](/filings/0000063754-26-000037.md) | [37.6%](/filings/0000063754-26-000192.md) | [37.5%](/filings/0000063754-26-000274.md) | [37.4%](/filings/0000063754-26-000329.md) | [38.9% d](/filings/0000063754-26-000037.md) | [37.8%](/filings/0000063754-26-000192.md) | [40.2%](/filings/0000063754-26-000274.md) | [39.3%](/filings/0000063754-26-000329.md) |
| Operating margin | % | [17.0% d](/filings/0000063754-26-000037.md) | [14.0%](/filings/0000063754-26-000192.md) | [14.8%](/filings/0000063754-26-000274.md) | [16.7%](/filings/0000063754-26-000329.md) | [16.8% d](/filings/0000063754-26-000037.md) | [12.1%](/filings/0000063754-26-000192.md) | [14.3%](/filings/0000063754-26-000274.md) | [10.7%](/filings/0000063754-26-000329.md) |
| Net margin | % | [12.0% d](/filings/0000063754-26-000037.md) | [10.1%](/filings/0000063754-26-000192.md) | [10.5%](/filings/0000063754-26-000274.md) | [13.1%](/filings/0000063754-26-000329.md) | [12.2% d](/filings/0000063754-26-000037.md) | [54.2%](/filings/0000063754-26-000192.md) | [7.8%](/filings/0000063754-26-000274.md) | [4.8%](/filings/0000063754-26-000329.md) |
| Diluted EPS | $ per share | not reported | [0.60](/filings/0000063754-26-000192.md) | [0.65](/filings/0000063754-26-000274.md) | [0.84](/filings/0000063754-26-000329.md) | not reported | [3.77](/filings/0000063754-26-000192.md) | [0.56](/filings/0000063754-26-000274.md) | [0.36](/filings/0000063754-26-000329.md) |
| Free cash flow | $m | [373 d](/filings/0000063754-26-000037.md) | [78.4](/filings/0000063754-26-000192.md) | [(2.4) d](/filings/0000063754-26-000274.md) | [206 d](/filings/0000063754-26-000329.md) | [458 d](/filings/0000063754-26-000037.md) | [18.4](/filings/0000063754-26-000192.md) | [337 d](/filings/0000063754-26-000274.md) | [112 d](/filings/0000063754-26-000329.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-11-30) | FY2022 (2022-11-30) | FY2023 (2023-11-30) | FY2024 (2024-11-30) | FY2025 (2025-11-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,318](/filings/0000063754-24-000027.md) | [6,351](/filings/0000063754-25-000005.md) | [6,662](/filings/0000063754-26-000037.md) | [6,724](/filings/0000063754-26-000037.md) | [6,840](/filings/0000063754-26-000037.md) |
| Gross margin | % | [39.5%](/filings/0000063754-24-000027.md) | [35.8%](/filings/0000063754-25-000005.md) | [37.6%](/filings/0000063754-26-000037.md) | [38.5%](/filings/0000063754-26-000037.md) | [37.9%](/filings/0000063754-26-000037.md) |
| Operating margin | % | [16.1%](/filings/0000063754-24-000027.md) | [13.6%](/filings/0000063754-25-000005.md) | [14.5%](/filings/0000063754-26-000037.md) | [15.8%](/filings/0000063754-26-000037.md) | [15.7%](/filings/0000063754-26-000037.md) |
| Net margin | % | [12.0%](/filings/0000063754-24-000027.md) | [10.7%](/filings/0000063754-25-000005.md) | [10.2%](/filings/0000063754-26-000037.md) | [11.7%](/filings/0000063754-26-000037.md) | [11.5%](/filings/0000063754-26-000037.md) |
| Diluted EPS | $ per share | [2.80](/filings/0000063754-24-000027.md) | [2.52](/filings/0000063754-25-000005.md) | [2.52](/filings/0000063754-26-000037.md) | [2.92](/filings/0000063754-26-000037.md) | [2.93](/filings/0000063754-26-000037.md) |
| Free cash flow | $m | [550](/filings/0000063754-24-000027.md) | [390](/filings/0000063754-25-000005.md) | [973](/filings/0000063754-26-000037.md) | [647](/filings/0000063754-26-000037.md) | [740](/filings/0000063754-26-000037.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mkc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.06bn | 20,948,941 |  | Reduced −324,830 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $837.3m | 16,607,445 |  | Added +95,233 |
| [STATE FARM MUTUAL AUTOMOBILE INSURANCE CO](/funds/315032.md) | 2026-06-30 | $833.1m | 16,522,728 |  | Unchanged |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $772.7m | 15,326,182 |  | Reduced −19,024 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $698.4m | 13,850,739 |  | Reduced −13,877 |
| [Aristotle Capital Management, LLC](/funds/860644.md) | 2026-06-30 | $574.2m | 11,388,915 |  | Reduced −1,275,463 |
| [Sanders Capital, LLC](/funds/1508097.md) | 2026-06-30 | $408.8m | 8,107,755 |  | New +8,107,755 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $364.6m | 7,230,202 |  | Added +2,824,752 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $342.1m | 6,812,505 |  | Added +147,095 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $248.7m | 4,932,093 |  | Added +1,102,723 |

## Recent filings

[All 2,687 filings](/companies/mkc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 20:36 ET | [10-Q](/filings/0000063754-26-000329.md) | Quarterly report, period 2026-08-31 | 0000063754-26-000329 |
| 2026-10-01 | 11:31 ET | [8-K](/filings/0000063754-26-000326.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000063754-26-000326 |
| 2026-09-28 | 20:38 ET | [8-K](/filings/0000063754-26-000322.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000063754-26-000322 |
| 2026-08-28 | 20:16 ET | [8-K](/filings/0000063754-26-000305.md) | 5.02 Departure or appointment of officers or directors | 0000063754-26-000305 |
| 2026-08-12 | 19:55 ET | [SCHEDULE 13D/A](/filings/0001193125-26-346767.md) | Ownership report, active investor, amended | 0001193125-26-346767 |
| 2026-06-25 | 20:37 ET | [10-Q](/filings/0000063754-26-000274.md) | Quarterly report, period 2026-05-31 | 0000063754-26-000274 |
| 2026-06-25 | 11:24 ET | [8-K](/filings/0000063754-26-000270.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000063754-26-000270 |
| 2026-05-26 | 20:16 ET | [8-K](/filings/0000063754-26-000232.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000063754-26-000232 |
| 2026-05-01 | 12:30 ET | [8-K](/filings/0001999371-26-009633.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-009633 |
| 2026-04-17 | 17:44 ET | [8-K](/filings/0000063754-26-000212.md) | 5.02 Departure or appointment of officers or directors | 0000063754-26-000212 |

## Latest annual report

[Form 10-K for the fiscal year ended Nov 30, 2025](/filings/0000063754-26-000037.md), filed Jan 22, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 63754
- Tickers: MKC, MKC-V
- Exchange: NYSE
- SIC code: 2090 Miscellaneous Food Preparations & Kindred Products
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.